Recombinant Human IL6R Protein, MYC/DDK-tagged
Cat.No. : | IL6R-2176H |
Product Overview : | Recombinant human IL6R protein, fused to MYC/DDK-tagged at C-terminus, was expressed in HEK293 |
- Specification
- Gene Information
- Related Products
Description : | Low concentration of a soluble form of IL6 receptor acts as an agonist of IL6 activity. [UniProtKB/Swiss-Prot Function] |
Source : | HEK293 |
Species : | Human |
Tag : | MYC/DDK |
Form : | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol. |
Molecular Mass : | 49.8 kDa |
Purity : | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Concentration : | >50 ug/mL as determined by microplate BCA method |
Gene Name : | IL6R interleukin 6 receptor [ Homo sapiens ] |
Official Symbol : | IL6R |
Synonyms : | CD126; gp80; IL-6R-1; IL-6RA; IL6Q; IL6RA; IL6RQ |
Gene ID : | 3570 |
mRNA Refseq : | NM_000565 |
Protein Refseq : | NP_000556 |
MIM : | 147880 |
UniProt ID : | P08887 |
Products Types
◆ Recombinant Protein | ||
IL6R-517H | Recombinant Human IL6R Protein, C13 and N15 Labeled | +Inquiry |
IL6R-1058H | Recombinant Human IL-6 Protein | +Inquiry |
IL6R-070H | Recombinant Human IL6R Protein, C-His-tagged | +Inquiry |
IL6R-139I | Active Recombinant Human IL6R Protein (350 aa), N-His-tagged | +Inquiry |
IL6R-1046H | Recombinant Human IL6R protein(Met1-Pro365), hFc-tagged | +Inquiry |
◆ Lysates | ||
IL6R-2903HCL | Recombinant Human IL6R cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThe dose and route of administration need to be determined according to the specific treatment situation. Common routes of administration include subcutaneous injection and intravenous injection.
It can be used to treat certain autoimmune diseases, such as rheumatoid arthritis and psoriasis.
The IL6R is primarily used to treat inflammatory diseases that have already occurred, rather than prevent them.
IL6R reduces inflammation by binding to interleukin-6 (IL-6), blocking the IL-6 signaling pathway.
Although IL6R can regulate the immune system, it is not a direct anti-tumor drug.
The efficacy of IL6R is usually evaluated based on improvement of clinical symptoms, changes in disease activity, and changes in biochemical markers.
Customer Reviews (3)
Write a reviewGood compatibility and stability with the surfactant.
Expression level and stability of clones were good.
Remarkable antibacterial activity and bactericidal effect on bacteria.
Ask a Question for All IL6R Products
Required fields are marked with *
My Review for All IL6R Products
Required fields are marked with *
Inquiry Basket